|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
Human influenza hemagglutinin (HA) is a surface glycoprotein required for the infectivity of the human virus. The HA tag is derived from the HA-molecule corresponding to amino acids 98-106 has been extensively used as a general epitope tag in expression vectors. Many recombinant proteins have been engineered to express the HA tag, which does not appear to interfere with the bioactivity or the biodistribution of the recombinant protein. This tag facilitates the detection, isolation, and purification of the proteins.
The actual HA tag is as follows: 5' TAC CCA TAC GAT GTT CCA GAT TAC GCT 3' or 5' TAT CCA TAT GAT GTT CCA GAT TAT GCT 3' The amino acid sequence is: YPYDVPDYA.
|Rat IL22 ORF mammalian expression plasmid, C-GFPSpark tag||RG80463-ACG|
|Rat IL22 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||RG80463-ACR|
|Rat IL22 ORF mammalian expression plasmid, C-Flag tag||RG80463-CF|
|Rat IL22 ORF mammalian expression plasmid, C-His tag||RG80463-CH|
|Rat IL22 ORF mammalian expression plasmid, C-Myc tag||RG80463-CM|
|Rat IL22 ORF mammalian expression plasmid, C-HA tag||RG80463-CY|
|Rat IL22 Gene cDNA clone plasmid||RG80463-G|
|Rat IL22 ORF mammalian expression plasmid, N-Flag tag||RG80463-NF|
|Rat IL22 ORF mammalian expression plasmid, N-His tag||RG80463-NH|
|Rat IL22 ORF mammalian expression plasmid, N-Myc tag||RG80463-NM|
|Rat IL22 ORF mammalian expression plasmid, N-HA tag||RG80463-NY|
|Rat IL22 natural ORF mammalian expression plasmid||RG80463-UT|
|Learn more about expression Vectors|
IL22 is a member of a group of cytokines called the IL-10 family or IL-10 superfamily (including IL-19, IL-20, IL-24, and IL-26), a class of potent mediators of cellular inflammatory responses. It shares use of IL-10R2 in cell signaling with other members of this family, IL-10, IL-26, IL-28A/B and IL-29. IL22 is produced by activated DC and T cells and initiates innate immune responses against bacterial pathogens especially in epithelial cells such as respiratory and gut epithelial cells. IL22 along with IL-17 is rapidly produced by splenic LTi-like cells and can be also produced by Th17 cells and likely plays a role in the coordinated response of both adaptive and innate immune systems.
IL22 biological activity is initiated by binding to a cell-surface complex composed of IL-22R1 and IL-10R2 receptor chains and further regulated by interactions with a soluble binding protein, IL-22BP, which shares sequence similarity with an extracellular region of IL-22R1 (sIL-22R1). IL22 and IL-10 receptor chains play a role in cellular targeting and signal transduction to selectively initiate and regulate immune responses. IL22 can contribute to immune disease through the stimulation of inflammatory responses, S100s and defensins. IL22 also promotes hepatocyte survival in the liver and epithelial cells in the lung and gut similar to IL-10. In some contexts, the pro-inflammatory versus tissue-protective functions of IL22 are regulated by the often co-expressed cytokine IL-17A.